Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
88.39
+2.43 (2.83%)
At close: Nov 21, 2024, 4:00 PM
88.30
-0.09 (-0.10%)
After-hours: Nov 21, 2024, 6:37 PM EST
Vaxcyte Employees
Vaxcyte had 254 employees as of December 31, 2023. The number of employees increased by 96 or 60.76% compared to the previous year.
Employees
254
Change (1Y)
96
Growth (1Y)
60.76%
Revenue / Employee
n/a
Profits / Employee
-$1,998,614
Market Cap
11.02B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 254 | 96 | 60.76% |
Dec 31, 2022 | 158 | 69 | 77.53% |
Dec 31, 2021 | 89 | 31 | 53.45% |
Dec 31, 2020 | 58 | 15 | 34.88% |
Dec 31, 2019 | 43 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Encompass Health | 37,761 |
Dr. Reddy's Laboratories | 27,048 |
Solventum | 20,098 |
Smith & Nephew | 19,081 |
Catalent | 17,800 |
AptarGroup | 13,800 |
Globus Medical | 5,000 |
Bio-Techne | 3,050 |
PCVX News
- 9 days ago - Vaxcyte Provides Positive Regulatory Updates on VAX-31 Pediatric and Adult Programs - GlobeNewsWire
- 16 days ago - Vaxcyte Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Vaxcyte to Present at the 2024 Cantor Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Vaxcyte's Broad-Spectrum Pneumococcal Vaccines Poised For Market Dominance By 2027 - Seeking Alpha
- 2 months ago - Vaxcyte Announces Closing of $1.5 Billion Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 2 months ago - Vaxcyte: Stunning PCV Data Readout Suggests Vaccine Maker Is A Strong Buy - Seeking Alpha
- 2 months ago - Vaxcyte's stock dips after biotech completes $1.42 billion stock offering - Market Watch
- 2 months ago - Vaxcyte to raise $1.3 bln from shares, warrants sale after stock's surge to record high - Reuters